IPSEN group: subsidiaries and structure
SA à conseil d'administration (s.a.i.) · PARIS, France · LEI 549300M6SGDPB4Z94P11
3subsidiaries
1countries
1held directly
1lapsed LEIs
3links on accounts older than 24 months
0ISINs of subsidiaries
Summary
IPSEN is the ultimate parent of 3 subsidiaries with LEIs in 1 country, as reported to GLEIF. 1 is held directly; the others sit below intermediate companies. All of them are in France. 1 of the subsidiaries has a lapsed LEI, and 3 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 13 ISINs for the parent and 0 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
3 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
IPSEN PHARMA France
MAYOLY PHARMA FRANCE France
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| IPSEN PHARMA | France | PARIS | 96950004ZQHLJ6V8PJ87 | 2017 | > 24 months |
| IPSEN PHARMA BIOTECH | France | SIGNES | 5493004FKHE4DDKBY188 | 2016 | lapsed > 24 months |
| MAYOLY PHARMA FRANCE | France | RUEIL-MALMAISON | 5493004DPENXG1LRV442 | 2020 | > 24 months |